IL10RA and inflammatory bowel disease: Unlike VEO-IBD patients with IL10/IL10R mutations, who are often difficult to treat and may need hematopoietic stem cell transplants, the disease in this patient has been well controlled for over a year now on standard immunosuppressive treatments with complete resolution of GI symptoms.